Sistance and glucose intolerance (Landsberg, 1996, 2001), nonetheless metabolic dysfunction is often present in lean OSA subjects (Pamidi et al., 2012). In CIH rodent models metabolic dysfunction is present without the obesity component (Carreras et al., 2012; Fenik et al., 2012; Wang et al., 2013; Shin et al., 2014), because it was described that animals submitted to CIH achieve significantly less weight (Carreras et al., 2012) or the comparable weight (Olea et al., 2014) in comparison with controls. Also, the amounts of perirenal and epididymal fat located in CIH animals was equivalent to these discovered in controls (Olea et al., 2014). Taken collectively these results show that in OSA, obesity just isn’t the only factor that contributes to metabolic dysfunction. The involvement of CB has been recently proposed as certainly one of the hyperlinks involving CIH and sympathetic overactivity and metabolic dysfunction, given that CB denervation prevents CIHinduced fasting hyperglycemia, even though CB denervation was incapable of avoid insulin resistance (Shin et al., 2014), suggesting that other mechanisms can account for the CIH inducedinsulin resistance. Actually, little is known with regards to the molecular mechanisms behind this partnership, with all the reduction of Glut4 metabolic fraction in skeletal muscle in CIH animals becoming the only mechanism described (Carreras et al., 2012). Hence, detailed research around the molecular mechanisms of insulin action in insulin-sensitive tissues will contribute enormously to improved comprehend the paradigm of CIH-induced insulin resistance, and so the partnership involving OSA and metabolic dysfunction.FUTURE PERSPECTIVESIn the final couple of years, various reports of non-classical roles from the CB on glucose homeostasis and metabolic regulation havefrontiersin.orgOctober 2014 | Volume 5 | Short article 418 |Conde et al.Carotid body and metabolic dysfunctionbeen published, contributing to launch the CB as a putative therapeutic target for the treatment of endocrine diseases. Our group has been actively involved within the procedure and not too long ago we described that chronic CB overstimulation is implicated in the etiology of diet-induced insulin resistance (Ribeiro et al., 2013). We have also described that surgical resection with the CSN prevents the development of dysmetabolic modifications induced by hypercaloric therapies in rats (Ribeiro et al., 2013), an observation that contributed to strengthen that CB blockade/modulation represents a novel and unexploited therapeutic approach.1345728-51-9 Chemical name In addition to the surgical resection from the CB, its overactivation can also be prevented pharmacologically with an old, well-studied and very safe drug: caffeine.Price of (3S)-(-)-3-(Dimethylamino)pyrrolidine Sustained caffeine administration prevents the improvement of hypertension, impaired glucose tolerance and insulin resistance in prediabetes animal models (Conde et al.PMID:33470050 , 2012b; Panchal et al., 2012). The protective effect of chronic caffeine administration was accompanied by prevention of weight get and decreased visceral fat in obese animals; nonetheless caffeine also exerted its optimistic metabolic effects in lean models of insulin resistance and hypertension independently of weight reduction (Conde et al., 2012b). A putative mechanism associated with blockade of adenosine receptors in the CBs and, as a result, with all the inhibition of CB-mediated sympathetic overactivation by chronic caffeine administration has been proposed as a paradigm shift to clarify the reduction of insulin resistance, blood pressure and type two diabetes threat induced by sustained consumption of this.